Binimetinib Products | Cleanchem - Binimetinib is a MEK inhibitor used in the treatment of certain types of cancer, including melanoma. It works by inhibiting a protein that promotes cancer cell growth, helping to slow the progression of the disease. It is often used in combination with other cancer therapies.

N-Nitroso Binimetinib

Cat. No: CL-BNM-NO-01

CAS No: NA

Mol. F: C17H14BrF2N5O4

Mol. Wt: 470.2

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 1

Cat. No: CL-BNM-NO-02

CAS No: NA

Mol. F: C17H14BrF2N5O4

Mol. Wt: 470.23

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 2

Cat. No: CL-BNM-NO-03

CAS No: NA

Mol. F: C16H12BrF2N5O4

Mol. Wt: 456.2

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 3

Cat. No: CL-BNM-NO-04

CAS No: NA

Mol. F: C21H22BrF2N5O5

Mol. Wt: 542.34

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 4

Cat. No: CL-BNM-NO-05

CAS No: NA

Mol. F: C20H20BrF2N5O5

Mol. Wt: 528.31

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 5

Cat. No: CL-BNM-NO-06

CAS No: NA

Mol. F: C16H12BrF2N5O4

Mol. Wt: 456.2

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 6

Cat. No: CL-BNM-NO-07

CAS No: NA

Mol. F: C16H11BrF2N4O3

Mol. Wt: 425.19

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 7

Cat. No: CL-BNM-NO-08

CAS No: NA

Mol. F: C17H14BrF2N5O4

Mol. Wt: 470.23

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 8

Cat. No: CL-BNM-NO-09

CAS No: NA

Mol. F: C30H19Br2F4N9O3

Mol. Wt: 789.34

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 9

Cat. No: CL-BNM-NO-10

CAS No: NA

Mol. F: C30H19Br2F4N9O3

Mol. Wt: 789.34

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 10

Cat. No: CL-BNM-NO-11

CAS No: NA

Mol. F: C29H17Br2F4N9O3

Mol. Wt: 775.32

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 11

Cat. No: CL-BNM-NO-12

CAS No: NA

Mol. F: C29H17Br2F4N9O3

Mol. Wt: 775.32

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 12

Cat. No: CL-BNM-NO-13

CAS No: NA

Mol. F: C17H15BrF2N6O4

Mol. Wt: 485.25

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 13

Cat. No: CL-BNM-NO-14

CAS No: NA

Mol. F: C16H13BrF2N6O4

Mol. Wt: 471.22

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 14

Cat. No: CL-BNM-NO-15

CAS No: NA

Mol. F: C32H23Br2F4N9O5

Mol. Wt: 849.4

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 15

Cat. No: CL-BNM-NO-16

CAS No: NA

Mol. F: C31H21Br2F4N9O5

Mol. Wt: 835.37

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 16

Cat. No: CL-BNM-NO-17

CAS No: NA

Mol. F: C23H12BrF2N5O5

Mol. Wt: 556.28

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 17

Cat. No: CL-BNM-NO-18

CAS No: NA

Mol. F: C22H10BrF2N5O5

Mol. Wt: 542.25

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 18

Cat. No: CL-BNM-NO-19

CAS No: NA

Mol. F: C14H5BrF2N4O3

Mol. Wt: 395.12

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 19

Cat. No: CL-BNM-NO-20

CAS No: NA

Mol. F: C17H13BrF2N4O3

Mol. Wt: 439.22

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 20

Cat. No: CL-BNM-NO-21

CAS No: NA

Mol. F: C23H22BrF2N5O10

Mol. Wt: 646.35

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 21

Cat. No: CL-BNM-NO-22

CAS No: NA

Mol. F: C22H20BrF2N5O10

Mol. Wt: 632.33

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 22

Cat. No: CL-BNM-NO-23

CAS No: NA

Mol. F: C22H14Br2F3N5O4

Mol. Wt: 629.19

Inv. Status: Custom Synthesis

N-Nitroso Binimetinib Impurity 23

Cat. No: CL-BNM-NO-24

CAS No: NA

Mol. F: C20H20BrF2N5O4

Mol. Wt: 512.31

Inv. Status: Custom Synthesis